Sarepta Therapeutics | Focused on precision genetic medicines to treat

- sarepta.com

Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 5 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders, totali

341,531 $ 25,920.00


The Leader in RNA-based Medicine | Sarepta Therapeutics

- avibio.com

We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.

Not Applicable $ 8.95

The Leader in RNA-based Medicine | Sarepta Therapeutics

- sareptatherapeutics.com

We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.

Not Applicable $ 8.95


Web Site Not Found

- okta.business
Not Applicable $ 8.95